Overview
Peng-sheng Zheng practices practicing medicine in Xi'an, China.
Zheng is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Cervical Cancer, Cervical Dysplasia, and Infertility.
They are actively involved in clinical research, co-authoring 50 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Peng-sheng S. Zheng
Is Peng-sheng S. Zheng a top-rated expert for Cervical Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Peng-sheng S. Zheng is classified as an Advanced expert for Cervical Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Peng-sheng S. Zheng participate in research or clinical trials?
Yes. Peng-sheng S. Zheng has published 50 articles and abstracts on conditions like Cervical Cancer. You can view a list of Peng-sheng S. Zheng's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cervical CancerZheng isAdvanced. Learn about Cervical Cancer.
- Experienced
- Cervical DysplasiaZheng isExperienced. Learn about Cervical Dysplasia.
- InfertilityZheng isExperienced. Learn about Infertility.